Abbott Case Reflects FDA Focus On "Medically Necessary" Product GMPs

The recent Abbott consent decree should alert manufacturers that FDA is serious about GMP compliance for "medically necessary" products, FDA Deputy Chief Counsel for Litigation Eric Blumberg told the Food & Drug Law Institute meeting in Washington, D.C. Dec. 17.